Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection

Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection

The rapid and large-scale roll-out of new COVID-19 vaccines has led to unprecedented challenges in assessing vaccine safety. In 2021, the European Medicines Agency (EMA) processed about 1.7 million safety reports related to COVID-19 vaccines in the EudraVigilance (EV) database and identified more th...

Full description

Bibliographic Details
Main Authors: Christelle Bizimungu, Martine Sabbe, Françoise Wuillaume, Jamila Hamdani, Philippe Koch, Jean-Michel Dogné
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Vaccines
Subjects:
COVID-19
vaccines
safety
pharmacovigilance
adverse event
causality
Online Access:https://www.mdpi.com/2076-393X/11/5/954

Internet

https://www.mdpi.com/2076-393X/11/5/954

Similar Items